CardioGenesis Data From 900 Additional Patients May Push PMR Over Top
This article was originally published in The Gray Sheet
Executive Summary
CardioGenesis is hoping that its PMR percutaneous myocardial revascularization system can be approved by early 2003 without a second panel review
You may also be interested in...
Cardiogenesis Starts Clinical Trial For Its Pearl Robotic TMR System
Cardiogenesis is developing a minimally-invasive transmyocardial revascularization (TMR) procedure for use on its Pearl 5.0 robotic laser delivery system, which is expected to receive FDA clearance within a few months
Cardiogenesis Starts Clinical Trial For Its Pearl Robotic TMR System
Cardiogenesis is developing a minimally-invasive transmyocardial revascularization (TMR) procedure for use on its Pearl 5.0 robotic laser delivery system, which is expected to receive FDA clearance within a few months
CardioGenesis Prepares For New Trial Of Percutaneous Laser Angina Device
CardioGenesis credits the recent regulatory progress of its Axcis laser percutaneous myocardial channeling (PMC) system to the contributions of Syncardia CEO Marvin Slepian, MD